Similar Papers

Paper Title
Journal
Date
Author
Researchers find discordance between standard human epidermal growth factor receptor 2 (HER2) testing and HER2 status reported on Oncotype DX
Mary Kay Barton
CA: A Cancer Journal for Clinicians | VOL. 62
Mary Kay BartonMary Kay Barton
18 Jan 2012
Reassignment of HER2 status for subgroups of breast cancer according to the 2018 updated American Society of Clinical Oncology and College of American Pathologists guidelines: The impact of combined immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) reflex testing in a large national reference laboratory.
Katherine Geiersbach ... Sara M Kloft-Nelson
Journal of Clinical Oncology | VOL. 37
Katherine Geiersbach, et. al.Katherine Geiersbach ... Sara M Kloft-Nelson
20 May 2019
Automated Quantitative RNA in Situ Hybridization for Resolution of Equivocal and Heterogeneous ERBB2 (HER2) Status in Invasive Breast Carcinoma
Zhen Wang ... Raymond R Tubbs
The Journal of Molecular Diagnostics | VOL. 15
Zhen Wang, et. al.Zhen Wang ... Raymond R Tubbs
08 Jan 2013
Assessment of HER2 gene amplification in breast cancer: a comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization
Xiaoyan Zhou ... Xu Cai
Chinese Journal of Pathology | VOL. 43
Xiaoyan Zhou, et. al.Xiaoyan Zhou ... Xu Cai
01 Apr 2014
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Risk factors for mortality and financial burdens in patients with colon cancer.
Zaid Zahid ... Lisa A Duhaime
Journal of Clinical Oncology | VOL. 43
Zaid Zahid, et. al.Zaid Zahid ... Lisa A Duhaime
01 Feb 2025
Disparities in organ preservation rate for high-risk stage I rectal cancer.
Annmarie Butare ... Michael Honaker
Journal of Clinical Oncology | VOL. 43
Annmarie Butare, et. al.Annmarie Butare ... Michael Honaker
01 Feb 2025
Differences in disease characteristics in young vs older adults with colorectal carcinoma.
Shivani Modi ... Adit Dharia
Journal of Clinical Oncology | VOL. 43
Shivani Modi, et. al.Shivani Modi ... Adit Dharia
01 Feb 2025
Sex differences in toxicities and survival outcomes among patients with stage III colorectal cancer receiving adjuvant fluoropyrimidine monotherapy: A pooled analysis of four randomized controlled trials (JCOG2310A).
Hidekazu Hirano ... Yukihide Kanemitsu
Journal of Clinical Oncology | VOL. 43
Hidekazu Hirano, et. al.Hidekazu Hirano ... Yukihide Kanemitsu
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.